Craig A Collard is Director of Sierra Oncology, Inc.. Currently has a direct ownership of 0 shares of SRRA, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2022, when has been sold 13,500 shares (Common Stock) at a price of $55.0 per share, resulting in proceeds of $742,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Craig A Collard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2022
SELL
Sale (or disposition) back to the issuer
$742,500 $55.0 p/Share
13,500 Reduced 100.0%
0 Common Stock
Nov 24 2021
BUY
Open market or private purchase
$182,388 $23.09 p/Share
7,899 Added 36.91%
13,500 Common Stock
Nov 23 2021
BUY
Open market or private purchase
$128,543 $22.95 p/Share
5,601 Added 50.0%
5,601 Common Stock

Also insider at

OPNT
OPIANT PHARMACEUTICALS, INC. Healthcare
TRSSF
TerrAscend Corp. Healthcare
HRTX
HERON THERAPEUTICS, INC. Healthcare
CAC

Craig A Collard

Director
Mississauga, A6

Track Institutional and Insider Activities on SRRA

Follow Sierra Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRRA shares.

Notify only if

Insider Trading

Get notified when an Sierra Oncology, Inc. insider buys or sells SRRA shares.

Notify only if

News

Receive news related to Sierra Oncology, Inc.

Track Activities on SRRA